Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era

Nakshbandi, Gizal; Moor, Catharina C.; Johannson, Kerri A.; Maher, Toby; Kreuter, Michael; Wijsenbeek, Marlies

doi:10.1183/23120541.00405-2021

Cited by 16 publications

(18 citation statements)

References 16 publications

(15 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This percentage is similar to other estimates obtained from clinicians where it was shown that 42% started using e-health in patients with ILD during COVID-19 Open access pandemic. 39 Our findings support the results of Nakshbandi et al 39 and show that most clinicians who use telehealth believe it to be quite effective in patients with ILD. Further support is seen in a physician-respondent survey by Walia et al 40 The survey shows a significant shift towards telehealth training and that the quality of telehealth is similar to face-to-face visits.…”

Section: Discussionsupporting

confidence: 90%

“…These barriers include factors like lack of organisational structure (80%), technical issues (63%) and lack of time and/or workload (63%). A previous study by Nakshbandi et al 39 reported similar challenges to telehealth adaptation. Similarly, Walia et al 40 reported challenges like lack of organisational support, inadequate telehealth technology and training.…”

Section: Discussionmentioning

confidence: 69%

“…Despite advances in telehealth technology and ease of useability, technical issues were seen as one of the main barriers to adaptation of telehealth in patients with ILD. 39 Maher et al 35 raised similar concerns related to technical issues with home-based spirometry data variability. However, a potential solution to technical issues and barriers reported by clinicians lies in helpdesk services, training and administrative support.…”

Section: Discussionmentioning

confidence: 98%

See 2 more Smart Citations

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians

Althobiani

Alqahtani²,

Hurst

et al. 2021

BMJ Open Resp Res

View full text Add to dashboard Cite

IntroductionClinicians and policymakers are promoting widespread use of home technology including spirometry to detect disease progression for patients with interstitial lung disease (ILD); the COVID-19 pandemic has accelerated this. Data collating clinicians’ views on the potential utility of telehealth in ILD are limited.AimThis survey investigated clinicians’ opinions about contemporary methods and practices used to monitor disease progression in patients with ILD using telehealth.MethodsClinicians were invited to participate in a cross-sectional survey (SurveyMonkey) of 13 questions designed by an expert panel. Telehealth was defined as home monitoring of symptoms and physiological parameters with regular automatic transmission of data from the patient’s home to the clinician. Data are presented as percentages of respondents.ResultsA total of 207 clinicians from 23 countries participated in the survey. A minority (81, 39%) reported using telehealth. 50% (n=41) of these respondents completed a further question about the effectiveness of telehealth. A majority of respondents (32, 70%) rated it to be quite or more effective than face-to-face visit. There were a greater number of respondents using telehealth from Europe (94, 45%) than Asia (51, 25%) and America (24%). Clinicians reported the most useful telehealth monitoring technologies as smartphone apps (59%) and wearable sensors (30%). Telehealth was most frequently used for monitoring disease progression (70%), quality of life (63%), medication use (63%) and reducing the need for in-person visits (63%). Clinicians most often monitored symptoms (93%), oxygen saturation (74%) and physical activity (72%). The equipment perceived to be most effective were spirometers (43%) and pulse oximeters (33%). The primary barriers to clinicians’ participation in telehealth were organisational structure (80%), technical challenges (63%) and lack of time and/or workload (63%). Clinicians considered patients’ barriers to participation might include lack of awareness (76%), lack of knowledge using smartphones (60%) and lack of confidence in telehealth (56%).ConclusionThe ILD clinicians completing this survey who used telehealth to monitor patients (n=81) supported its’ clinical utility. Our findings emphasise the need for robust research in telehealth as a mode for the delivery of cost-effective healthcare services in ILD and highlight the need to assess patients’ perspectives to improve telehealth utility in patients with ILD.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Discussionmentioning

confidence: 69%

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians

Althobiani

Alqahtani²,

Hurst

et al. 2021

BMJ Open Resp Res

View full text Add to dashboard Cite

show abstract

“…In recent assessments of home monitoring for patients with ILD, healthcare providers were interested to use home monitoring for regular care and research purposes [ 83 ]. Although these findings are encouraging, further studies considering clinician perspectives are necessary.…”

Section: Discussionmentioning

confidence: 99%

Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review

et al. 2021

View full text Add to dashboard Cite

BackgroundAcute exacerbations and disease progression in interstitial lung disease (AE-ILD) pose important challenges to clinicians and patients. AE-ILD are variable in presentation but may result in rapid progression of ILD, respiratory failure and death. However, in many cases AE-ILD may go unrecognised so that their true impact and response to therapy is unknown. The potential for home monitoring to facilitate early, and accurate, identification of AE and/or ILD progression has gained interest. With increasing evidence available, there is a need for a systematic review on home monitoring of patients with ILD to summarise the existing data.AimTo systematically evaluate the evidence for use of home monitoring for early detection of exacerbations and/or progression of ILD.MethodWe searched Ovid-EMBASE, MEDLINE, and CINAHL using MeSH terms in accordance with the PRISMA guidelines. PROSPERO registration number (CRD42020215166).ResultsThirteen studies comprising 968 patients have demonstrated that home monitoring is feasible and of potential benefit in patients with ILD. Nine studies reported that mean adherence to home monitoring was greater than 75%, and where spirometry was performed there was a significant correlation (r=0.72–0.98, p<0.001) between home and hospital-based readings. Two studies suggested that home monitoring of Forced Vital Capacity (FVC) might facilitate detection of progression in idiopathic pulmonary fibrosis (IPF).ConclusionDespite the fact that individual studies in this systematic review provide supportive evidence suggesting the feasibility and utility of home monitoring in ILD, further studies are necessary to quantify the potential of home monitoring to detect disease progression and/or acute exacerbations.

show abstract

“…), even though the positive experiences gained regarding eHealth (e.g. (Feijt et al, 2020;Nakshbandi et al, 2021;Wang et al, 2021)).…”

Section: Graduation Committeementioning

confidence: 99%

eHealth - In or out of our daily lives? Measuring the (non-)use of eHealth in summative evaluations

Hurmuz¹

View full text Add to dashboard Cite

All rights reserved. No parts of this thesis may be reproduced, stored in a retrieval system or transmitted in any form or by any means without permission of the author. Alle rechten voorbehouden. Niets uit deze uitgave mag worden vermenigvuldigd, in enige vorm of op enige wijze, zonder voorafgaande schriftelijke toestemming van de auteur. EHEALTH -INOR OUT OF OUR DAILY LIVES? MEASURING THE (NON-)USE OF EHEALTH IN SUMMATIVE EVALUATIONS DISSERTATION to obtain the degree of doctor at the University of Twente, on the authority of the rector magnificus, prof. dr. ir. A. Veldkamp, on account of the decision of the Doctorate Board, To be publicly defended on Thursday 16 June 2022 at 14.

show abstract

Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era

Cited by 16 publications

References 16 publications

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians

Telehealth for patients with interstitial lung diseases (ILD): results of an international survey of clinicians

Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review

eHealth - In or out of our daily lives? Measuring the (non-)use of eHealth in summative evaluations

Contact Info

Product

Resources

About